Exploring Non-Drug Treatments for Fibromyalgia

Understanding Fibromyalgia

Fibromyalgia is a chronic condition characterized by significant muscle pain and tenderness. This debilitating disease can severely impact an individual’s quality of life, affecting social and familial relationships. While fibromyalgia is prevalent in both genders, it is more frequently diagnosed in women, affecting approximately 3% to 10% of the general population. A common symptom of this condition is persistent fatigue.

Current Treatment Options

Traditional treatments for fibromyalgia primarily involve pharmacological approaches, which operate through anti-inflammatory, analgesic, and antidepressant mechanisms. Additional strategies, such as exercise and dietary modifications, are also employed to alleviate symptoms. Exercise is believed to enhance energy levels and reduce muscle weakness, while adopting a gluten-free diet may help decrease inflammation.

Alternative Treatments: Laser and Ultrasound

Research Initiatives

In response to the demand for non-drug, non-invasive treatments for fibromyalgia, researchers from Brazil have investigated the use of laser and ultrasound therapies. Laser therapy has demonstrated anti-inflammatory and analgesic effects by influencing specific enzymes in mitochondria, leading to increased ATP production. Ultrasound therapy alleviates pain through its thermal effects and by modifying nerve conduction pathways.

Study Overview

A recent study published in *The Journal of Novel Physiotherapies* by researchers at the Optics and Photonics Research Centre, supported by the São Paulo Research Foundation, examined the effects of low-intensity laser light and therapeutic ultrasound applied to the palms of fibromyalgia patients’ hands. The treatment protocol involved a three-minute application, performed twice a week for ten sessions.

The study enrolled 48 women aged 40 to 65 who had been diagnosed with fibromyalgia. Participants were divided into six groups of eight at the Clinical Research unit managed by IFSC-USP in collaboration with the Santa Casa de Misericórdia hospital in São Carlos, São Paulo. Three groups received laser or ultrasound treatments separately or in combination on the trapezius muscle, while the other three groups received treatments solely on the palms of their hands.

Findings and Implications

Comparative Effectiveness of Treatments

The pilot study allowed for a direct comparison of the effects of low-intensity laser light and therapeutic ultrasound, both in isolation and in combination. The combination of these modalities, referred to as ultra laser, was particularly notable. The evaluation utilized the Fibromyalgia Impact Questionnaire and Visual Analogue Scale to assess patient outcomes.

Results indicated that treatment applied to the palms of the hands was the most effective, regardless of the technique used. However, the combination of laser and ultrasound therapies resulted in the most significant improvements. Specifically, patients receiving ultrasound-laser treatment at the trapezius region experienced a 46.6% improvement in functionality and a 63.31% reduction in pain compared to those receiving ultrasound alone. In contrast, the ultrasound-laser group treated on the palms of the hands reported a remarkable 75.37% reduction in pain, highlighting the superior efficacy of this approach.

Conclusion and Future Research Directions

This pilot study suggests that novel non-drug, non-invasive treatments for fibromyalgia, particularly when applied to the palms of the hands, may offer promising results. Given the lack of a cure for this condition and its substantial impact on patients’ lives, further exploration of these treatment modalities is warranted.

References

1) Silva amaral bruno, J et al. 2018. Could Hands be a New Treatment to Fibromyalgia? A pilot study. [Online]. [7 October 2018]. Available from: https://www.omicsonline.org/peer-reviewed/could-hands-be-a-new-treatment-to-fibromyalgia-a-pilot-study-102098.html
2) Eurekalert. 2018. Ultralaser treatment for fibromyalgia yields 75 percent pain reduction when applied to the hands. [Online]. [7 October 2018]. Available from: https://www.eurekalert.org/pub_releases/2018-08/fda-utf082918.php